SUN PHARMACEUTICAL INDUSTRIES, INC.

Lobbying for SUN PHARMACEUTICAL INDUSTRIES, INC. · Pharmaceuticals

Filing Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Jul 7, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Lobbying activity 3

Health Issues

232 tariffs, drug pricing

Medicare/Medicaid

232 tariffs, drug pricing

Trade (domestic/foreign)

232 tariffs, drug pricing

Foreign interests disclosed 4

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

SHANGHVI FINANCE PRIVATE LIMITED

India · Vile Parle (East), Mumbai · owns 40.30% of the client · contributed $0.00
SUN PHARMACEUTICAL INDUSTRIES LIMITED

India · Goregaon (East), Mumbai · owns 100% of the client · contributed $0.00
SUN PHARMA HOLDINGS UK LTD.

United Kingdom · Uxbridge · owns 96.35% of the client · contributed $0.00
SUN PHARMA (NETHERLANDS) B.V.

Netherlands · Hoofddorp · owns 96.35% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.